4th edition
Barcelona Health Innovation Week

Biologic formulations face stability challenges that surfactants help overcome. In this webinar, Croda experts share surfactant selection strategies for biotherapeutics, featuring never-before-seen stability data comparing polysorbates, poloxamers, and innovative alternatives to enhance protein integrity and performance.

Join us at an event that goes beyond the presentation of experiences, methodologies, and innovative solutions in digital health. This gathering will offer a practical insight into the process of creating and implementing innovations in a real hospital setting. Through authentic cases and experiences, we will explore how integrating the patient’s voice is essential for improving outcomes, optimising efficiency, enhancing healthcare coordination, and empowering patients. During the event, there will be an interactive exhibition offering participants the opportunity to test digital tools developed by the hospital’s various innovation teams. This will be a unique occasion to experience first-hand how these solutions are transforming current clinical practice and reshaping the future of healthcare.

This event focuses on how to transform research into real solutions for the healthcare system and society. We will present the most innovative results from the Complementary Biotechnology Plan, explore technological transfer strategies with experts, and share success stories that are paving the way for the medicine of the future. A space to connect researchers and companies.

ELEPHANT is the second edition of a bold space, where everything intersects: patients, families, professionals, hospitals, and startups sit at the same table. From lived experiences to innovative solutions, we discuss what no one else is talking about, make the invisible visible, and co-create a more human-centered health system, together.

This session will focus on innovation in digital health and knowledge transfer among companies, research centers, and public entities. Organized by Arvor and IDIAP Jordi Gol, it will gather players from the health ecosystem to discuss major challenges and trends. The event will include two round tables and short pitches from emerging initiatives, fostering dialogue, collaboration, and networking.

A practical LEGO® Serious Play® workshop to discover unmet healthcare needs to which you can apply your research. This hands-on workshop invites PhD students to step back and explore the real-world relevance of their research using the LEGO® Serious Play® methodology. Through individual building and guided reflection, you’ll clarify what your research truly stands for, the unmet needs it could address, and what currently stands between knowledge and application. We will use the LEGO® Serious Play® methodology, a creative and innovative way to visualize different ideas about the challenges facing research and how to make it useful to society. A practical, creative space to think differently, gain clarity, and reconnect with the purpose and potential of your work.

This presentation will explore ongoing research efforts aimed at broadening the therapeutic landscape by including innovative treatment modalities such as mRNA delivery systems, vaccination strategies or cell therapies. We will elaborate on the pros and cons of the different advanced modalities and will focus on the design of the appropriate preclinical discovery platforms needed along the drug development pathway. The choice of modality is influenced by many different factors and impacts the journey of the drug development with respect to platforms, cell sources and read-outs. We will elaborate on scientific, regulatory, technical, and logistical considerations related to the respective modality using HER2 as one of the cornerstones of cancer therapeutics.

ISGlobal’s Antimicrobial Resistance Initiative (AMR) presents a comprehensive catalogue of innovative services, resources and programmes aimed at addressing one of the most pressing global health challenges. The catalogue includes digital tools, educational materials, training courses, citizen science activities, practical workshops and active projects that connect research, dissemination, community participation and support for public policies. This proposal provides a comprehensive framework to promote transformative actions in the field of antimicrobial resistance, with a multidisciplinary approach based on research, pedagogy and the One Health model. The resources are designed for a wide variety of audiences – citizens, health professionals, educational communities, local governments and social entities – and are offered both in self-use format and in on-demand activities. The catalogue highlights innovative initiatives such as: – Citizen science programs (SAFE, ENDEMIC) – Practical workshops such as Let’s do an antibiogram! or creative-educational activities for children and young people – Digital tools and virtual laboratories to understand and visualize the AMR – Certified courses for health professionals – Multilingual outreach resources (infographics, videos, printable materials, blog, scrolling) – Active projects in public health, the environment and One Health This activity is presented as an opportunity to give visibility to a set of innovative actions that promote knowledge, prevention and collective response to antimicrobial resistance, with a strong educational, participatory and social impact component.

From Failure to Founder is a programme promoted by Xartec Salut, that explores failure as a key learning tool in innovation and entrepreneurship. It aims to help researchers turn knowledge into real-world impact through transfer, industry collaboration or spin-offs, learning from those who have faced challenges before. The online session features Dani Tost (Virmedex) & Isaac Cano (Health Circuit).

Clinical evaluation is often addressed only at the end of technical documentation development—but starting it early can significantly streamline your pathway to compliance and strengthen your product strategy. Join this webinar to discover how early clinical evaluation can guide and support your development process from day one.

Join us to explore the scientific and creative power of UBNeuro’s Cognitive Neuroscience Unit. Discover how we advance brain‑computer interfaces, neuromodulation, and multimodal behavior research. Built on translational science, knowledge sharing, and tech innovation, we help neurotechnology grow from early ideas to real‑world market needs.

SID, in collaboration with 60Nd, present NeoMag, an innovative device designed to non-invasively reproduce mechanical stimuli in biological cells. The session will showcase key advantages of this technology, focusing its potential to enhance biomedical research and drug discovery by anticipating therapeutic failures associated with mechanical factors oftenly overlooked in conventional approaches.

A program based on the health innovation cycle of CIMTI, offering all the necessary training for healthcare professionals to drive innovation initiatives in their clinical fields: from the conceptualization of an unmet need (phase 1), to the description of the potential solution to that need (phase 2), to the proof of concept (phase 3). The training covers the clinical, business, regulatory, and technological areas.

Discover the evolving landscape of paediatric health investment with our upcoming i4KIDS Training Capsule. Marc Ramis, partner of Ship2B Ventures, will share insights on current trends, emerging opportunities, and how innovative models, such as the Montana Children’s Health Fund, are helping build impactful paediatric health companies.

The Can Ruti Innova Demo Day is the final event of Hospital Germans Trias i Pujol’s flagship innovation programme, which since 2020 has supported healthcare professionals in turning clinical needs into viable projects. After months of training and mentoring, teams pitch their solutions to an expert jury and a live audience. Join us to discover emerging ideas and connect with innovators!

Midas is organising 3 workshops, followed by networking drinks & snacks.

Request for re-defining starting materials can pose a significant risk to a marketing authorization application
This real-world case study shows how deep process understanding, impurity profiling, and targeted experiments aligned with ICH guidelines Q3A, Q11, and M7 are essential to overcome major concerns and challenges

How can research software generate real-world impact? Using CRG as a case study, this seminar presents Open Source, Academic Non-Commercial and Commercial licensing paths, and shows how the CRG Technology & Business Development Office (TBDO) helps researchers turn code into innovation, collaboration and technology transfer.

Two experience-sharing roundtables with coffee break: Session 1, Innovating Beyond Research, co-organised by IR Sant Pau and Nucleate, explores researchers’ and clinicians’ transition into entrepreneurship. Session 2, Digital Transformation in Healthcare: Public-Private Collaboration Opportunities, shares startup experiences validating digital solutions in clinical practice.

Midas is organising 3 workshops, followed by networking drinks & snacks Discover how analytical science enables successful development of biologics and biosimilars. Explore real-world challenges in mAbs and ADCs, from molecular complexity and comparability to stability and regulatory expectations, highlighting advanced analytical tools and practical insights shaping the future of biologics

If your company belongs to the healthcare sector, medical technology, medical devices, or digital health, this session will help you understand the structure and main characteristics of the sector in the United States so you can successfully do business there. Program

• The U.S. healthcare market: opportunities and challenges. How the new International Expansion Service of the Foreign Office in New York can help.
• The Most Common Mistakes Healthtech Companies Make: practical insights on market validation, regulation, capital, sales, reimbursement, and data security.

The MAR Tech Transfer Academy provides researchers and clinicians with practical tools to translate lab innovations into market and patient impact. Through monthly masterclasses and interactive sessions (January – June 2026), experts will cover strategies across the Technology, Business, Science and Clinical pillars. In this case, this session program will be open to the Ecosystem.

This virtual session explores the journey of Advanced Therapy Medicinal Products from research to clinical use. Experts will discuss key regulatory, QA/QC and CMC challenges, the transition from lab-scale to GMP manufacturing, and how engineering and translational research converge to design future-ready ATMP production facilities.

Midas is organising 3 workshops, followed by networking drinks & snacks. Abstract: We’ll explore real-world case studies, address common challenges in regulatory strategy and development planning, and share practical guidance to help you navigate them effectively. Let’s move smarter toward your next milestone.

How are the most important financing deals in the health sector shaped? Within the framework of Barcelona Health Innovation Week, we met at Hospital Clínic to analyze the private investment milestones of 2025 from a privileged perspective: that of the lawyers who led the closing of these transactions.

In this session, Francisco Aránega (AMyS – Aránega, Miravitlles & Suárez Abogados), Elena Cuatrecasas (Cuatrecasas) and David Miranda (Osborne Clarke) will share first-hand insights into the key legal structures, negotiation challenges, and lessons learned from the funding rounds of companies such as SpliceBio (€118 million, Series B), DeepUll (€50 million, Series C), and Qida (€37 million, Series B), which set the pace for the ecosystem last year.”